Dose Finding Study of Ibrutinib Plus Lenalidomide / Rituximab in Relapsed or Refractory Mantle Cell Lymphoma
Hackensack Meridian Health
Hackensack Meridian Health
Ohio State University Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)
Dana-Farber Cancer Institute
Northwestern University
Amgen
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Stanford University
Ipsen
University of Pennsylvania
Brown University
Fred Hutchinson Cancer Center
ADC Therapeutics S.A.
ADC Therapeutics S.A.
Fred Hutchinson Cancer Center
Gilead Sciences
Fred Hutchinson Cancer Center
Dartmouth-Hitchcock Medical Center
Massachusetts General Hospital
Pfizer
Ohio State University Comprehensive Cancer Center